S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells

Molecules and Cells

Volumn 35, Issue 3, 2013, Pages 226-234

  Kwon, Chae Hwa ^a   Moon, Hyun Jung ^a   Park, Hye Ji ^a   Choi, Jin Hwa ^a   Park, Do Youn ^a  

^a Pusan National University Hospital   (South Korea)

Author keywords

gastric cancer cells; MMP; NF B; p38MAPK; S100A8 A9

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALGRANULIN A; CALGRANULIN B; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER;

CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 2; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIDINES; STOMACH NEOPLASMS;

EID: 84880046097     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-2269-x     Document Type: Article

References (38)

1. Aggarwal, B.B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208.
2. Ang, C.W., Nedijadi, T.A., Sheikh, A.M., Tweedle, E., Tonack, S., Honap, S.E., Jenkins, R., Park, B.K., Schwarte-Waldhoff, I., Khattak, I., et al. (2010). Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis 31, 1541-1551.
3. Choi, J.H., Shin, N.R., Moon, H.J., Kwon, C.H., Kim, G.H., Song, G.A., Jeon, T.Y., Kim, D.H., and Park, D.Y. (2012). Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. Histol. Histopathol. 27, 1439-1448.
4. Dong, W., Li, H., Zhang, Y., Yang, H., Guo, M., Li, L., and Liu, T. (2011). Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim. Biophys. Sin. 43, 840-848.
5. Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
6. Foell, D., Wittkowski, H., Vogl, T., and Roth, J. (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28-37.
7. Gebhardt, C., Nemeth, J., Angel, P., and Hess, J. (2006). S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622-1631.
8. Gebhardt, C., Riehl, A., Durchdewald, M., Nemeth, J., Furstenberger, G., Muller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P.P., et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205, 275-285.
9. Ghavami, S., Kerkhoff, C., Los, M., Hashemi, M., Sorg, C., and Karami-Tehrani, F. (2004). Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol. 76, 169-175.
10. Ghavami, S., Kerkhoff, C., Chazin, W.J., Kadkhoda, K., Xiao, W., Zuse, A., Hashemi, M., Eshraghi, M., Schulze-Osthoff, K., Klonisch, T., et al. (2008a). S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta. 1783, 297-311.
11. Ghavami, S., Rashedi, I., Dattilo, B.M., Eshraghi, M., Chazin, W.J., Hashemi, M., Wesselborg, S., Kerkhoff, C., and Los, M. (2008b). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukocyte Biol. 83, 1484-1492.
12. Ghavami, S., Chitayat, S., Hashemi, M., Eshraghi, M., Chazin, W.J., Halayko, A.J., and Kerkhoff, C. (2009). S100A8/A9: a Janusfaced molecule in cancer therapy and tumorgenesis. Eur. J. Pharmacol. 625, 73-83.
13. Hermani, A., De Servi, B., Medunganin, S., Tessier, P.A., and Mayer, D. (2006). S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell. Res. 312, 184-197.
14. Hiratsuka, S., Watanabe, A., Aburantani, H., and Maru, Y. (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375.
15. Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake K., Shibuya, M., Akira, S., Aburatani, H., and Maru, Y. (2008). The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349-1355.
16. Hofmann, H.S., Hansen, G., Richter, G., Taege, C., Simm, A., Silber, R.E., and Burdach, S. (2005). Matrixproteinase-12 expression correlates with local recurrence and metastatic desease in non-small cell lung cancer patients. Clin. Cancer Res. 11, 1086-1092.
17. Ichikawa, M., Williams, R., Wang, L., Vogl, T., and Srikrichna, G. (2011). S100A8/A9 acrivate key genes and pathways in colon tumor progression. Mol. Cancer Res. 9, 133-148.
18. Joyce, J.A., and Pollard, J.W. (2009). Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252.
19. Kerkela, E., Ala-aho, R., Klemi, P., Grenman, S., Shapiro, S.D., Kahari, V.M., and Saarialho-Kere, U. (2002). Metalloelastease (MMP-12) expression by tumour squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J. Pathol. 198, 258-269.
20. Li, J., Lau, G.K., Chen, L., Dong, S.S., Lan, H.Y., Huang, X.R., Li, Y., Luk, J.M., Yuan, Y.F., and Guan, X.Y. (2011). Interlukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6, e21816.
21. Moon, A., Yong, H.Y., Song, J.I., Cukovic, D., Salagrama, S., Kaplan, D., Putt, D., Kim, H., Dombkowski, A., and Kim, H.R. (2008). Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res. 6, 1544-1553.
22. Nacken, W., and Kerkhoff, C. (2007). The hetero-oligomeric complex of the S100A8/A9 protein is extremely protease resistant. FEBS Lett. 581, 5127-5130.
23. Nacken, W., Roth, J., Sorg, C., and Kerkhoff, C. (2003). S100A9/S100A8: Myeloid representative of the S100 protein family ac prominent players in innate immunity. Microsc. Res. Tech. 60, 569-580.
24. Ng, K.T., Qi, X., Kong, K.L., Cheung, B.Y., Lo, C.M., Poon, R.T., Fan, S.T., and Man, K. (2011). Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur. J. Cancer 47, 2299-2305.
25. Rao, J.S. (2003). Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3, 489-501.
26. Roth, J., Goebeler, M., and Sorg, C. (2001). S100A8 and S100A9 in inflammatory diseases. Lancet 257, 1041.
27. Roth, J., Vogl, T., Sorg, C., and Sunderkötter, C. (2003). Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155-158.
28. Roy, R., Yang, J., and Moses, M.A. (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287-5297.
29. Rychman, C., Vandal, K., Rouleau, P., Talbot, M., and Tessier, P.A. (2003). Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutophilchemotaxis and adhesion. J. Immunol. 170, 3233-3242.
30. Salama, I., Malone, P.S., Mihaimeed, F., and Jones, J.L. (2008). A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357-364.
31. Sheikh, A.A., Vimalachandran, D., Thompson, C.C., Jenkins, R.E., Nedjadi, T., Shekouh, A., Campbell, F., Dodson, A., Prime, W., Crnogorac-Jurcevic, T., et al. (2007). The expression of S100A8 in pancreatic cancer-associated monocyte is associated with the Smad4 status of pancreatic cancer cells. Proteomics 7, 1929-1940.
32. Silva, D. (2004). Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr. Cancer Drug Targets 4, 327-336.
33. Smith, M.G., Hold, G.L., Tahara, E., and El-Omar, E.M. (2006). Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 12, 2979-2990.
34. Takada, Y., Singh, S., and Aggarwal, B.B. (2004). Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in downregulation of NF-kappaB-mediated gene expression and upregulation of apoptosis. J. Biol. Chem. 279, 15096-15104.
35. Turovskaya, O., Foell, D., Shiha, P., Vogl, T., Newlin, R., Nayak, J., Nguyen, M., Olsson, A., Nawroth, P.P., Bierhus, A., et al. (2008). RAGE, carboxylatedglycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29, 2035-2043.
36. Whiteside, T.L. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904-5912.
37. Yong, H.Y., and Moon, A. (2007). Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res. 30, 75-81.
38. Zhao, Z.S., Wang, Y.Y., Chu, Y.Q., Ye, Z.Y., and Tao, H.Q. (2010). SPARC is associated with gastric cancer progression and poor survival of patients. Clin. Cancer Res. 16, 260-268.